Hookipa Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,290 | $36,599 | $7,407 | $6,867 |
Gross Profit | 576 | 35,959 | 6,129 | 6,380 |
EBITDA | -21,690 | 13,015 | -16,851 | -22,670 |
EBIT | -22,404 | 12,375 | -18,129 | -23,157 |
Net Income | -19,095 | 14,383 | -24,818 | -19,066 |
Net Change In Cash | 1,290 | 36,599 | 7,407 | 6,867 |
Free Cash Flow | -14,421 | -24,272 | -11,646 | -27,137 |
Cash | 77,150 | 92,751 | 117,096 | 107,676 |
Basic Shares | 12,538 | 12,597 | 9,895 | 11,038 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $20,129 | $14,249 | $18,448 | $19,584 |
Gross Profit | 16,577 | 14,249 | 18,448 | 19,584 |
EBITDA | -81,376 | -69,553 | -77,034 | -49,135 |
EBIT | -84,928 | -73,155 | -81,674 | -53,285 |
Net Income | -81,580 | -65,145 | -75,666 | -33,801 |
Net Change In Cash | 20,129 | 14,249 | 18,448 | 19,584 |
Cost of Revenue | 47,257 | -78,832 | 31,710 | |
Free Cash Flow | -61,683 | -25,014 | -78,597 | -41,710 |
Cash | 117,096 | 113,444 | 66,912 | 143,177 |
Basic Shares | 9,452 | 6,557 | 3,289 | 2,608 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.52 |
2024-03-31 | $0.11 |
2023-12-31 | -$0.22 |
2023-09-30 | -$0.17 |
